Morpholino

MO2-gata1a

ID

ZDB-MRPHLNO-050208-11

Name

MO2-gata1a

Previous Names

Target

Sequence

5' - GTTTGGACTCACCTGGACTGTGTCT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

A splice blocking morpholino targeting the first exon/intron boundary of gata1.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-gata1a

Expressed Gene	Anatomy	Figures
hamp	liver	Fig. 7 from Fraenkel et al., 2009

Phenotype

Phenotype resulting from MO2-gata1a

No data available

Phenotype of all Fish created by or utilizing MO2-gata1a

Phenotype	Fish	Conditions	Figures
whole organism Ab3-spi1 labeling amount, ameliorated	mitfa^w2/w2; mpv17^a9/a9 + MO2-gata1a	chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor	Fig. 7 from Tyrkalska et al., 2019
whole organism Ab2-gata1a labeling decreased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO2-gata1a	control	Fig. 4, Fig. 7 from Tyrkalska et al., 2019
whole organism Ab3-spi1 labeling increased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO2-gata1a	control	Fig. 7 from Tyrkalska et al., 2019
whole organism Ab2-gata1a labeling amount, ameliorated	mitfa^w2/w2; mpv17^a9/a9 + MO2-gata1a	chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor	Fig. 7 from Tyrkalska et al., 2019
nucleate erythrocyte decreased amount, ameliorated	mitfa^w2/w2; mpv17^a9/a9 + MO2-gata1a	chemical treatment by environment: EC 3.4.22.36 (caspase-1) inhibitor	Fig. 7 from Tyrkalska et al., 2019
nucleate erythrocyte decreased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO2-gata1a	control	Fig. 7 from Tyrkalska et al., 2019

Citations